TerrAscend Closes on Ohio Dispensary Acquisition
TerrAscend (TSNDF) has completed its acquisition of Ratio Cannabis LLC, a cannabis dispensary in Goshen Township, Ohio. This strategic move marks TerrAscend's entry into its sixth U.S. state and expands its retail footprint to 39 dispensaries across six U.S. states and Canada. The acquired dispensary generates $9 million in annualized revenue and enjoys a competitive advantage with no competition within a 20-mile radius.
The acquisition is expected to be immediately accretive to EBITDA and cashflow. TerrAscend plans to continue its expansion in Ohio through additional dispensary acquisitions, up to the state's limit of eight dispensaries.
TerrAscend (TSNDF) ha completato l'acquisizione di Ratio Cannabis LLC, un dispensario di cannabis situato a Goshen Township, Ohio. Questa mossa strategica segna l'ingresso di TerrAscend nel suo sesto stato degli Stati Uniti e amplia la sua presenza retail a 39 dispensari distribuiti in sei stati USA e in Canada. Il dispensario acquisito genera un fatturato annualizzato di 9 milioni di dollari e gode di un vantaggio competitivo grazie all'assenza di concorrenza entro un raggio di 20 miglia.
L'acquisizione dovrebbe avere un impatto immediato positivo su EBITDA e flusso di cassa. TerrAscend prevede di proseguire l'espansione in Ohio tramite ulteriori acquisizioni di dispensari, fino al limite massimo di otto dispensari consentito dallo stato.
TerrAscend (TSNDF) ha completado la adquisición de Ratio Cannabis LLC, un dispensario de cannabis en Goshen Township, Ohio. Este movimiento estratégico marca la entrada de TerrAscend en su sexto estado de EE.UU. y amplía su presencia minorista a 39 dispensarios en seis estados estadounidenses y Canadá. El dispensario adquirido genera 9 millones de dólares en ingresos anualizados y cuenta con una ventaja competitiva al no tener competencia en un radio de 20 millas.
Se espera que la adquisición incremente inmediatamente el EBITDA y el flujo de caja. TerrAscend planea continuar su expansión en Ohio mediante la adquisición de más dispensarios, hasta el límite estatal de ocho dispensarios.
TerrAscend (TSNDF)가 오하이오주 고션 타운십에 위치한 대마초 판매점 Ratio Cannabis LLC 인수를 완료했습니다. 이번 전략적 조치는 TerrAscend가 미국 내 6번째 주에 진출함을 의미하며, 미국 6개 주와 캐나다에 걸쳐 총 39개의 판매점으로 소매망을 확장하는 결과를 가져왔습니다. 인수한 판매점은 연간 900만 달러의 매출을 창출하며, 20마일 반경 내 경쟁자가 없어 경쟁 우위를 확보하고 있습니다.
이번 인수는 즉시 EBITDA와 현금 흐름에 긍정적인 영향을 미칠 것으로 예상됩니다. TerrAscend는 오하이오에서 주 허용 최대 8개 판매점까지 추가 인수를 통해 확장을 계속할 계획입니다.
TerrAscend (TSNDF) a finalisé l'acquisition de Ratio Cannabis LLC, un dispensaire de cannabis situé à Goshen Township, Ohio. Cette opération stratégique marque l'entrée de TerrAscend dans son sixième État américain et étend son réseau de vente au détail à 39 dispensaires répartis dans six États américains et au Canada. Le dispensaire acquis génère un chiffre d'affaires annualisé de 9 millions de dollars et bénéficie d'un avantage concurrentiel grâce à l'absence de concurrence dans un rayon de 20 miles.
Cette acquisition devrait immédiatement être bénéfique pour l'EBITDA et la trésorerie. TerrAscend prévoit de poursuivre son expansion dans l'Ohio par le biais d'acquisitions supplémentaires de dispensaires, jusqu'à la limite de huit dispensaires autorisée par l'État.
TerrAscend (TSNDF) hat die Übernahme von Ratio Cannabis LLC, einem Cannabis-Dispensary in Goshen Township, Ohio, abgeschlossen. Dieser strategische Schritt markiert den Eintritt von TerrAscend in seinen sechsten US-Bundesstaat und erweitert seine Einzelhandelspräsenz auf 39 Dispensaries in sechs US-Bundesstaaten und Kanada. Das erworbene Dispensary erwirtschaftet einen jährlichen Umsatz von 9 Millionen US-Dollar und verfügt über einen Wettbewerbsvorteil, da es im Umkreis von 20 Meilen keine Konkurrenz gibt.
Die Übernahme wird voraussichtlich sofort positiv auf EBITDA und Cashflow wirken. TerrAscend plant, seine Expansion in Ohio durch weitere Übernahmen von Dispensaries fortzusetzen, bis zum staatlich erlaubten Limit von acht Dispensaries.
- Immediate EBITDA and cashflow accretion expected from the acquisition
- Strong revenue generation of $9M annually from the acquired dispensary
- Strategic competitive advantage with no competition within 20-mile radius
- Expansion of retail footprint to 39 dispensaries across 6 U.S. states
- Opportunity for further growth with additional Ohio dispensary acquisitions (up to 8 allowed)
- None.
Transaction marks the Company’s entry into its sixth U.S. state
Acquisition is expected to be immediately accretive on an EBITDA and cashflow basis
TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced the closing of its previously announced acquisition of the assets of Ratio Cannabis LLC ("Ratio Cannabis"), a cannabis dispensary located in Goshen Township, Ohio. The acquisition represents TerrAscend's initial entry into its sixth state, Ohio, and is expected to be immediately accretive on an EBITDA and cashflow basis. This acquisition increases TerrAscend's retail footprint to 39 dispensaries across six U.S. states and Canada. The Company intends to acquire additional Ohio dispensaries in the future.
"Ratio Cannabis is a strong performer, with no competition within a 20-mile radius, generating
About TerrAscend
TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium, Gage and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com.
Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.
While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend’s operations and financial performance.
Forward-Looking Information
This press release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and include, but not limited to, statements with respect to the expected performance of Ratio Cannabis LLC, any changes to Ohio’s cannabis retail competitive landscape and the likelihood that the Company completed further acquisitions in Ohio. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by this release. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States; and the risk factors set out in the Company’s most recently filed MD&A, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR+ at www.sedarplus.ca and in the section titled “Risk Factors” in the Company’s Annual Report for the year ended December 31, 2024 filed with the Securities and Exchange Commission on March 6, 2025.
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether, as a result of new information, future events, or results or otherwise, other than as required by applicable securities laws.
For more information regarding TerrAscend:
Keith Stauffer
Chief Financial Officer
IR@terrascend.com
717-343-5386
Investor Relations Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
Valter@KCSA.com
212-896-1254
FAQ
What is TerrAscend's (TSNDF) latest acquisition in Ohio?
How much revenue does TerrAscend's newly acquired Ohio dispensary generate?
How many dispensaries does TerrAscend now operate after the Ohio acquisition?
What are TerrAscend's expansion plans in Ohio?
How will the Ratio Cannabis acquisition impact TerrAscend's financials?
